Rapport Therapeutics, Inc. (RAPP) Free cash flow 2023–2025
Rapport Therapeutics, Inc. (RAPP) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$88.1MFY2025 · since FY2023: -$28.8M → -$88.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$88.1M | -31.0% |
| FY2024 | -$67.2M | -133.3% |
| FY2023 | -$28.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More RAPP financial trends
RAPP RevenueRAPP Net incomeRAPP Net marginRAPP Gross profitRAPP Gross marginRAPP Operating incomeRAPP Operating marginRAPP Operating cash flowRAPP Capital expendituresRAPP Return on equityRAPP Stock buybacksRAPP Dividends paidRAPP Total assetsRAPP Total liabilitiesRAPP Shareholders’ equityRAPP overview →